| A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors (NCT03196284) | Novo Nordisk A/S | 2017-08-10 |
| Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer (NCT04072718) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2017-08-10 |
| A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer (NCT03186937) | University of Wisconsin, Madison | 2017-08-10 |
| Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma (NCT03200691) | Hangzhou Cancer Hospital | 2017-08-10 |
| RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy (NCT03118986) | The Hospital for Sick Children | 2017-08-10 |
| Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis (NCT02744222) | Biocad | 2017-08-10 |
| Selective Nerve Root Block With Ultrasound Guidance Improves Surgical Outcome of Selective Discectomy in Patients With Multilevel Cervical Disc Disease (NCT05145530) | Assiut University | 2017-08-10 |
| HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease (NCT03240731) | Centre Hospitalier Intercommunal Creteil | 2017-08-10 |
| Effects of Psilocybin in Major Depressive Disorder (NCT03181529) | Johns Hopkins University | 2017-08-10 |
| Pediatric Myocardial Protection With Potassium Cardioplegia (NCT03229980) | Assiut University | 2017-08-10 |
| Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area (NCT03101111) | Themis Bioscience GmbH | 2017-08-09 |
| Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials (NCT03207256) | TG Therapeutics, Inc. | 2017-08-09 |
| A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN (NCT03124368) | Alexion Pharmaceuticals, Inc. | 2017-08-09 |
| Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata (NCT03137381) | Concert Pharmaceuticals | 2017-08-09 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia (NCT03136146) | M.D. Anderson Cancer Center | 2017-08-09 |
| Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (NCT03198559) | University of Melbourne | 2017-08-08 |
| Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) (NCT03114527) | Fox Chase Cancer Center | 2017-08-08 |
| A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT03251443) | Peking Union Medical College Hospital | 2017-08-08 |
| Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) (NCT02689362) | Eurofarma Laboratorios S.A. | 2017-08-08 |
| A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors (NCT03184870) | Bristol-Myers Squibb | 2017-08-08 |
| A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis (NCT03224351) | Vertex Pharmaceuticals Incorporated | 2017-08-08 |
| Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma (NCT03177668) | Kissei Pharmaceutical Co., Ltd. | 2017-08-08 |
| OMO-1 in Solid Malignancies (NCT03138083) | Octimet Oncology N.V. | 2017-08-08 |
| Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors (NCT03238248) | Vanderbilt-Ingram Cancer Center | 2017-08-07 |
| Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome (NCT03355469) | Rutgers University | 2017-08-07 |
| A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity (NCT03238352) | GlaxoSmithKline | 2017-08-07 |
| Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines (NCT03155100) | Raija Silvennoinen | 2017-08-07 |
| Traumatic Brain Injury and Effects of Acute Cyclosporine A (NCT02496975) | Edward Hall,PhD | 2017-08-07 |
| Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects (NCT03178422) | Chrono Therapeutics, Inc. | 2017-08-07 |
| Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence? (NCT03232112) | Anders Fink-Jensen, MD, DMSci | 2017-08-07 |
| A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism (NCT03139487) | Asan Medical Center | 2017-08-07 |
| Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics (NCT03220776) | Medical University of South Carolina | 2017-08-07 |
| Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2 (NCT03208257) | Samuel Brown | 2017-08-07 |
| Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS (NCT03202394) | BioMarck Pharmaceuticals, Ltd. | 2017-08-05 |
| Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors (NCT02587962) | Medivir | 2017-08-04 |
| Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels (NCT03117972) | Centre Hospitalier Universitaire de Besancon | 2017-08-04 |
| Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts (NCT03160079) | University of California, San Diego | 2017-08-04 |
| Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (NCT03293173) | Nordic Lymphoma Group | 2017-08-04 |
| An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD (NCT03868566) | Sinew Pharma Inc. | 2017-08-04 |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer (NCT03181867) | National Cancer Institute (NCI) | 2017-08-03 |
| A Study of Nivolumab in Selected Uterine Cancer Patients (NCT03241745) | Memorial Sloan Kettering Cancer Center | 2017-08-03 |
| Fluoride Controlled-release System for Initial Lesions of Caries (NCT05139966) | Federal University of Paraíba | 2017-08-03 |
| Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) (NCT02935517) | Beacon Therapeutics | 2017-08-03 |
| Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab (NCT03126331) | Case Comprehensive Cancer Center | 2017-08-03 |
| A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (NCT03131453) | Novartis Pharmaceuticals | 2017-08-03 |
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer (NCT03179904) | Mayo Clinic | 2017-08-03 |
| N-Acetylcysteine for Youth Cannabis Use Disorder (NCT03055377) | Medical University of South Carolina | 2017-08-03 |
| Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia (NCT03559387) | Prolong Pharmaceuticals | 2017-08-03 |
| A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes (NCT03187301) | Sumitomo Pharma America, Inc. | 2017-08-03 |
| A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors (NCT03195478) | Bristol-Myers Squibb | 2017-08-02 |
| Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer (NCT02883062) | National Cancer Institute (NCI) | 2017-08-02 |
| A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) (NCT03199469) | Astellas Gene Therapies | 2017-08-02 |
| 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation (NCT03103490) | Stanford University | 2017-08-02 |
| CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO (NCT03227328) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2017-08-02 |
| A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes (NCT03235050) | AstraZeneca | 2017-08-02 |
| Melatonin for Adolescent Migraine Prevention Study (NCT03150797) | Amy Gelfand | 2017-08-02 |
| Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification (NCT03106155) | Samsung Medical Center | 2017-08-02 |
| Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies (NCT03217747) | M.D. Anderson Cancer Center | 2017-08-02 |
| Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome (NCT03231735) | University of Alabama at Birmingham | 2017-08-02 |
| Phase 2 Study of ONC201 in Neuroendocrine Tumors (NCT03034200) | Peter Anderson | 2017-08-02 |
| Neuroprotection in Acute Ischemic Stroke (NCT03320018) | Stony Brook University | 2017-08-02 |
| Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (NCT03167242) | Novartis Pharmaceuticals | 2017-08-02 |
| Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer (NCT03290209) | Fujian Medical University | 2017-08-01 |
| Neo-MASCT Immunotherapy for Advanced NSCLC. (NCT03205930) | The First People's Hospital of Lianyungang | 2017-08-01 |
| Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02709512) | Polaris Group | 2017-08-01 |
| Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer (NCT03253068) | Wakayama Medical University | 2017-08-01 |
| A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma (NCT03170882) | Millennium Pharmaceuticals, Inc. | 2017-08-01 |
| An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis (NCT03229252) | Spyryx Biosciences, Inc. | 2017-08-01 |
| Expanding the Pool in Orthotopic Heart Transplantation (NCT03222531) | Mary E. Keebler, MD | 2017-08-01 |
| Preemptive Analgesia for Primary Dysmenorrhoea (NCT03323671) | Hanan Nabil | 2017-08-01 |
| Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation (NCT03236220) | Peking University People's Hospital | 2017-08-01 |
| Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine (NCT03108469) | Smith, Timothy R., M.D. | 2017-08-01 |
| Study of Stereotactic Radiotherapy for Breast Cancer (NCT03043794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-08-01 |
| A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration (NCT03626636) | Allegro Ophthalmics, LLC | 2017-08-01 |
| Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial (NCT02655536) | National Taiwan University Hospital | 2017-08-01 |
| Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma (NCT02704858) | Neonc Technologies, Inc. | 2017-08-01 |
| The ICON Study: Outcomes After FMT for Patients With IBD and CDI (NCT03106844) | Brigham and Women's Hospital | 2017-08-01 |
| G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score (NCT03163862) | Istishari Arab Hospital | 2017-08-01 |
| Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668) (NCT03221634) | Merck Sharp & Dohme LLC | 2017-08-01 |
| A Study of Apatinib Treatment in for Advanced Ovarian Cancer (NCT03393507) | The People's Hospital of Leshan | 2017-08-01 |
| Grading Versus Classic Inferior Oblique Anterior Transposition in Patient With Asymmetric Dissociated Vertical Deviation (NCT03135938) | Shahid Beheshti University of Medical Sciences | 2017-08-01 |
| Medication Development for Opioid and Alcohol Abuse (NCT03205423) | New York State Psychiatric Institute | 2017-08-01 |
| A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts (NCT03158974) | ViroXis Corporation | 2017-08-01 |
| Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma (NCT03343665) | St. Petersburg State Pavlov Medical University | 2017-08-01 |
| Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD) (NCT03197493) | Snyder, Robert W., M.D., Ph.D., P.C. | 2017-08-01 |
| Painless Local Anaesthesia With Bicarbonate Admixture (NCT03238625) | University of Zurich | 2017-08-01 |
| Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease (NCT03240549) | Beijing Hospital | 2017-08-01 |
| A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder (NCT03144232) | Stanford University | 2017-08-01 |
| Mirabegron For Erectile Dysfunction (NCT02916693) | Johns Hopkins University | 2017-08-01 |
| Intranasal Oxytocin for Infants With Prader-Willi Syndrome (NCT03245762) | University of Florida | 2017-08-01 |
| The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers (NCT03211572) | Ottawa Hospital Research Institute | 2017-08-01 |
| Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation (NCT03135652) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2017-08-01 |
| A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor (NCT03219554) | Samsung Medical Center | 2017-08-01 |
| Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study (NCT03150628) | Richard van Hillegersberg | 2017-08-01 |
| Lidocaine Infusion in Hystroscopy (NCT03825016) | Ain Shams University | 2017-08-01 |
| Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas (NCT03149120) | NYU Langone Health | 2017-08-01 |
| Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma (NCT03097328) | Bradley A. McGregor, MD | 2017-08-01 |
| Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis (NCT03253094) | Scynexis, Inc. | 2017-08-01 |
| Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility (NCT03401918) | Stanford University | 2017-08-01 |